Medikaloka Hermina Tbk PT
IDX:HEAL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 070
1 595
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medikaloka Hermina Tbk PT
Wall Street
Price Targets
HEAL Price Targets Summary
Medikaloka Hermina Tbk PT
According to Wall Street analysts, the average 1-year price target for
HEAL
is 1 794.07 IDR
with a low forecast of 1 414 IDR and a high forecast of 2 100 IDR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Medikaloka Hermina Tbk PT
For the last 7 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's operating income is
14%.
The projected
CAGR
for the next 3 years is
22%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HEAL's stock price target?
Price Target
1 794.07
IDR
According to Wall Street analysts, the average 1-year price target for
HEAL
is 1 794.07 IDR
with a low forecast of 1 414 IDR and a high forecast of 2 100 IDR.
What is Medikaloka Hermina Tbk PT's Revenue forecast?
Projected CAGR
15%
For the last 7 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's revenue is
15%.
The projected
CAGR
for the next 3 years is
15%.
What is Medikaloka Hermina Tbk PT's Operating Income forecast?
Projected CAGR
22%
For the last 7 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's operating income is
14%.
The projected
CAGR
for the next 3 years is
22%.
What is Medikaloka Hermina Tbk PT's Net Income forecast?
Projected CAGR
27%
For the last 7 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's net income is
32%.
The projected
CAGR
for the next 3 years is
27%.
You don't have any saved screeners yet
